CanSino: Ad5-nCoV

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Convidecia

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 3 Trials

Phase 2: 3 Trials

Phase 3: 2 Trials

Approvals

5 Countries

Registered Trials